Exactech Continues To Expand Spine Portfolio With Comprehensive Solution To Posterior Cervical Fusion

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced the full market launch of its Gibralt® spinal system at the Cervical Spine Research Society Annual Meeting this week.

“Gibralt is another example of Exactech’s strategy to create innovative products through our in-house development team in collaboration with leading clinicians,” said Bruce Thompson, senior vice president and general manager of Exactech Biologics and Spine division. “We expect this product to enhance the level of patient care surgeons can provide in cervical and thoraco-cervical procedures.”

The Gibralt Spinal System is a comprehensive solution for posterior stabilization and an adjunct to fusion of the cervical and upper thoracic spine. Offering versatility and ease-of-use, Gibralt features top loading polyaxial screws, hooks, offset connectors, and rod-to-rod connectors which can be constructed into a multitude of configurations based individual patient anatomy. The low-profile pedicle screw with 80 degrees of motion is designed to reduce the risk of tissue impingement in the thoracic spine, and the EZ Set tulip head allows the tulip head to be easily positioned and set for rod insertion. The unique Tightlok™ thread technology of the thread provides high biomechanical strength, resisting screw pullout. With an option of transitional rods and a variety of connectors, Gibralt may be connected to lumbar pedicle screw systems, including Proliant® and Hydralok®.

Orthopaedic surgeon Erich Richter, M.D, associate professor of clinical neurosurgery at Louisiana State University Health Sciences and Gibralt design team member who performed the first case said, “I’m impressed with the versatility of the system. The EZ Set Polyaxial tulip head and low-profile cross connector allow for flexibility in assembling the construct.”

About Exactech

Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable investor information is available at http://www.exac.com and http://www.hawkassociates.com.

An investment profile on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.

This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.

1 2 Next › Last »